Bausch Health Companies Inc
NYSE:BHCView on Canadian Exchange

  • LAST PRICE
    6.2800
  • TODAY'S CHANGE (%)
    0.0800 (1.2903%)
  • Bid / Lots
    6.2100/ 2
  • Ask / Lots
    6.3400/ 2
  • Open / Previous Close
    6.2300 / 6.2000
  • Day Range
    6.2100
    6.3500
  • 52 Week Range
    6.0850
    11.4600
  • Volume
    1,456,756

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Pharmaceuticals - Diversified Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
BHC
Bausch Health Companies Inc
3.2B
-5.0x
---
OGN
Organon & Co
5.5B
5.1x
-14.04%
PRGO
Perrigo Company PLC
3.8B
8,354.4x
---
JAZZ
Jazz Pharmaceuticals PLC
6.6B
22.0x
-3.53%
CTLT
Catalent Inc
9.7B
-8.6x
---
AMRX
Amneal Pharmaceuticals Inc
2.1B
-12.1x
---
As of 2024-06-05

Company Information

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Contact Information

Headquarters
2150 Saint-Elzear Blvd WLAVAL, QC, Canada H7L 4A8
Phone
514-744-6792
Fax
514-744-6792

Executives

Independent Chairman of the Board
John Paulson
Chief Executive Officer, Director
Thomas Appio
Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Controller
John Barresi
Executive Vice President, General Counsel
Seana-Lyn Carson
Independent Director
Brett Icahn

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$2.4B
Revenue (TTM)
$9.0B
Shares Outstanding
361.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.82
EPS
$-1.24
Book Value
$-2.80
P/E Ratio
-5.0x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
3.0x
Operating Margin
12.06%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.